Regulation of RKIP function by Helicobacter pylori in gastric cancer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Moen, Erika L ^a   Wen, Sicheng ^a   Anwar, Talha ^a   Cross Knorr, Sam ^a   Brilliant, Kate ^a   Birnbaum, Faith ^a   Rahaman, Sherida ^b   Sedivy, John M ^c   Moss, Steven F ^a   Chatterjee, Devasis ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEASOME; RNA; SERINE; SERINE 153; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; VALINE;

APOPTOSIS; ARTICLE; ASSAY; CELL NUCLEUS; CONTROLLED STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LUCIFERASE TRANSCRIPTION REPORTER ASSAY; NUCLEIC ACID METABOLISM; PATHOGENICITY ISLAND; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; STOMACH EPITHELIUM; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANTIGENS, BACTERIAL; APOPTOSIS; BACTERIAL PROTEINS; CELL LINE, TUMOR; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN STABILITY; PROTEIN TRANSPORT; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); GASTROPODA; HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 84861467947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037819     Document Type: Article

References (50)

1. Garcia M, Jemal A, Ward E, Center M, Hao Y, et al. (2007) Global Cancer Facts & Figures 2007. American Cancer Society pp. 1-52.
2. Wroblewski LE, Peek RM Jr, Wilson KT, (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23: 713-739.
3. IARC working group on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes, Helicobacter pylori (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon 61: 1-270.
4. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, et al. (1998) Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114: 675-689.
5. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, et al. (1993) Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88: 1870-1875.
6. Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, et al. (2001) Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol 96: 1758-1766.
7. Sugimoto M, Yamaoka Y, Furuta T, (2010) Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol 16: 1188-1200.
8. Chen G, Sordillo EM, Ramey WG, Reidy J, Holt PR, et al. (1997) Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun 239: 626-632.
9. Wen S, Moss SF, (2009) Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 282: 1-8.
10. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR, (2005) Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 102: 16339-16344.
11. Lee IO, Kim JH, Choi YJ, Pillinger MH, Kim SY, et al. (2010) Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 285: 16042-16050.
12. Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, et al. (2009) Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 69: 632-639.
13. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, et al. (1996) STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87: 1692-1697.
14. Ni Z, Lou W, Lee SO, Dhir R, DeMiguel F, et al. (2002) Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol 167: 1859-1862.
15. Song JI, Grandis JR, (2000) STAT signaling in head and neck cancer. Oncogene 19: 2489-2495.
16. Watson CJ, Miller WR, (1995) Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer 71: 840-844.
17. Darnell JE Jr, (1997) STATs and gene regulation. Science 277: 1630-1635.
18. Yuan ZL, Guan YJ, Chatterjee D, Chin YE, (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307: 269-273.
19. Chatterjee D, Sabo E, Tavares R, Resnick MB, (2008) Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14: 2994-3001.
20. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, et al. (2004) STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23: 4921-4929.
21. Natalwala A, Spychal R, Tselepis C, (2008) Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 14: 3792-3797.
22. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, et al. (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456.
23. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
24. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
25. Beach S, Tang H, Park S, Dhillon AS, Keller ET, et al. (2008) Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27: 2243-2248.
26. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, et al. (2000) Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20: 3079-3085.
27. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, et al. (2001) Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21: 7207-7217.
28. Lorenz K, Lohse MJ, Quitterer U, (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426: 574-579.
29. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, et al. (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279: 17515-17523.
30. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, et al. (2004) Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 91: 169-200.
31. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, et al. (2003) Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 278: 13061-13068.
32. Wen S, So Y, Singh K, Slingerland JM, Resnick MB, et al. (2011) Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer. Oncogene.
33. Wen S, Felley CP, Bouzourene H, Reimers M, Michetti P, et al. (2004) Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J Immunol 172: 2595-2606.
34. Odenbreit S, Linder S, Gebert-Vogl B, Rieder G, Moran AP, et al. (2006) Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 11: 196-207.
35. Baritaki S, Yeung K, Palladino M, Berenson J, Bonavida B, (2009) Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Cancer Res 69: 8376-8385.
36. Peek RM Jr, Blaser MJ, (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
37. Chu SH, Lim JW, Kim KH, Kim H, (2003) NF-kappaB and Bcl-2 in Helicobacter pylori-induced apoptosis in gastric epithelial cells. Ann NY Acad Sci 1010: 568-572.
38. Ishihara S, Fukuda R, Kawashima K, Moriyama N, Suetsugu H, et al. (2001) T cell-mediated cytotoxicity via Fas/Fas ligand signaling in Helicobacter pylori-infected gastric corpus. Helicobacter 6: 283-293.
39. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, et al. (2007) Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2: 250-263.
40. Peek RM Jr, Wirth HP, Moss SF, Yang M, Abdalla AM, et al. (2000) Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118: 48-59.
41. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, et al. (2009) Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 136: 1297-1307, e1291-1293.
42. Minohara Y, Boyd DK, Hawkins HK, Ernst PB, Patel J, et al. (2007) The effect of the cag pathogenicity island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis. Helicobacter 12: 583-590.
43. Matsumoto A, Isomoto H, Nakayama M, Hisatsune J, Nishi Y, et al. (2011) Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells. Dig Dis Sci 56: 999-1006.
44. Shibayama K, Doi Y, Shibata N, Yagi T, Nada T, et al. (2001) Apoptotic signaling pathway activated by Helicobacter pylori infection and increase of apoptosis-inducing activity under serum-starved conditions. Infect Immun 69: 3181-3189.
45. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, et al. (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24: 5672-5679.
46. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, et al. (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95: 878-889.
47. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, et al. (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11: 7392-7397.
48. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK, (2006) Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 16: 451-456.
49. Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, et al. (2010) Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 59: 1037-1045.
50. Theroux S, Pereira M, Casten KS, Burwell RD, Yeung KC, et al. (2007) Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit. Brain Res Bull 71: 559-567.